Antony Koblish - Feb 24, 2022 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Chief Executive Officer, Director
Signature
/s/ Megan Smeykal, Attorney-in-fact
Stock symbol
TELA
Transactions as of
Feb 24, 2022
Transactions value $
$0
Form type
4
Date filed
2/25/2022, 04:11 PM
Next filing
Apr 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +46.5K +23.92% $0.00 241K Feb 24, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELA Stock Option (Right to Buy) Award $0 +79.5K $0.00 79.5K Feb 24, 2022 Common Stock 79.5K $11.98 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units will vest in four equal annual installments beginning on February 24, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2 The option vests 25% on February 24, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.